Revolutionizing Pharmaceutical Industry: The Power of Biomarkers and Personalized Medicine

The high failure rate in the pharmaceutical industry has sparked a growing interest in biomarkers and personalized medicine, offering a beacon of hope for enhancing the probability of success, accelerating time to market, and ultimately, benefiting patients. When executed correctly, biomarkers and companion diagnostics (CDx) can play a pivotal role in supporting accurate diagnosis and selection of the most effective and least toxic therapies.

Overcoming Challenges in Biomarkers and Laboratory Tests

This comprehensive guide delves into the challenges and limitations of biomarkers and laboratory tests, providing expert advice on best practices to ensure their proper application. By bridging the gap between diagnostic business development claims and real-life deliverables, this book offers a unique perspective on the utilization of biomarkers.

Diverse Applications of Biomarkers

The book covers biomarkers for various purposes, featuring examples from different technologies, including:

• Standard-of-care approved assays
• For-investigational-use and for-research-use-only assays

It also presents new data on biomarkers in different therapeutic indications, supplemented by case studies and practical examples.

A Valuable Resource for Professionals

This book serves as a reference guide for:

• Drug developers seeking to increase the probability of success in drug development
• IVD providers and clinical labs looking to improve patient management
• Healthcare givers, academicians, and researchers interested in biomarkers and personalized medicine

With over 200 illustrations and expert insights from an experienced author, this book provides a comprehensive understanding of the role of biomarkers in drug development and patient management.

Product Details

Published by Elsevier Science on June 8, 2019, this book is available in English. The ISBN numbers are 9780128161210 and 9780128161227.